Summary
A murine model system for evaluation of myocarditic and cardiotropic properties of strains of group B, type 4 coxsackievirus (CBV-4) was developed in male BALB/c mice 4 weeks of age. Differing cardiotropic and myocarditic properties could be identified among field strains within the CBV-4 serotype. These properties were consistent for the virus strains, and were independent of the infecting virus dose. Virus replication in the heart appeared to be essential for development of myocarditis, but some infected hearts with high levels of infectious virus did not show myocarditis. Two of the myocarditic strains showed different histopathology in infected hearts; with one strain (Mil) the myocarditis was characterized by a marked inflammatory reaction with occasional accompanying myofiber necrosis. With the other strain (Bol), necrosis was the predominant finding, with a much lesser degree of inflammation. These findings suggest that there may be various pathogenic or immunopathogenic mechanisms by which CBV-4 can produce myocarditis.
Similar content being viewed by others
References
Burch, G. E., DePasquale, N. P., Sun, S. C., Hale, A. R., Mogabgab, W. J.: Experimental coxsackievirus endocarditis. J. Amer. Med. Assn.196, 349–352 (1966).
Choppin, P. W., Eggers, H. J.: Heterogeneity of Coxsackie B4 virus: Two kinds of particles which differ in antibody sensitivity, growth rate, and plaque size. Virology18, 470–476 (1962).
El-Khatib, M. R., Chason, J. L., Ho, K.-L., Silberberg, B., Lerner, A. M.: Coxsackievirus B4 myocarditis in mice: valvular changes in virus-infected and control animals. J. Infect. Dis.137, 410–420 (1978).
Gray, F. G.: Spontaneous cardiac lesions in mice. Their bearing on attempts to produce experimental carditis. Am. J. Pathol.25, 1215–1225 (1949).
Grist, N. R.: Coxsackie virus infections of the heart. In:Waterson, A. P. (ed.), Recent Advances in Clinical Virology, 141–150. London: Churchill Livingstone 1977.
Grodums, E. I., Dempster, G.: The pathogenesis of Coxsackie group B viruses in experimental infection. Canad. J. Microbiol.8, 105–113 (1962).
Hartig, P. C., Madge, G. E., Webb, S. R.: Diversity within a human isolate of Coxsackie B4: Relationship to viral-induced diabetes. J. Med. Virol.11, 23–30 (1983).
Khatib, R., Chason, J. L., Silberberg, B. K., Lerner, A. M.: Age-dependent pathogenicity of group B coxsackieviruses in Swiss-Webster mice: Infectivity for myocardium and pancreas. J. Infect. Dis.141, 394–403 (1980).
Minnich, L. L., Ray, C. G.: Variable susceptibility of mice to group B coxsackievirus infections. J. Clin. Microbiol.11, 73–75 (1980).
Rytel, M. W., Kilbourne, E. D.: Differing susceptibility of adolescent and adult mice to non-lethal infection with coxsackievirus B3. Proc. Soc. Exp. Biol. & Med.137, 443–448 (1971).
Wigand, R., Sabin, A. B.: Intratypic antigenic heterogeneity of Coxsackie B viruses. Arch. Virusforsch.12, 29–41 (1962).
Wilson, F. M., Lerner, A. M.: A cardiomyopathy of BALB/c mice (superimposed infection by Coxsackievirus B-3). Proc. Soc. Exp. Biol. Med.157, 442–448 (1978).
Woodruff, J. F.: Viral myocarditis. Amer. J. Pathol.101, 425–483 (1980).
Author information
Authors and Affiliations
Additional information
With 2 Figures
Rights and permissions
About this article
Cite this article
Cao, Y., Schnurr, D.P. & Schmidt, N.J. Differing cardiotropic and myocarditic properties of group B type 4 coxsackievirus strains. Archives of Virology 80, 119–130 (1984). https://doi.org/10.1007/BF01310653
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01310653